EODData

NASDAQ, VRTX:

13 Aug 25 16:50
LAST:

395.9

CHANGE:
 8.15
OPEN:
391.5
HIGH:
396.7
ASK:
170.0
VOLUME:
1.91M
CHG(%):
2.10
PREV:
387.8
LOW:
386.8
BID:
149.8
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
13 Aug 25391.5396.7386.8395.91.91M
12 Aug 25377.6388.3375.0387.82.04M
11 Aug 25363.0380.2362.5374.52.79M
08 Aug 25377.0381.0364.7366.53.68M
07 Aug 25385.0388.3374.5375.64M
06 Aug 25375.8390.6372.4385.74.73M
05 Aug 25408.2414.9373.2375.010.73M
04 Aug 25466.5473.4462.1472.32.33M
01 Aug 25457.4464.2453.5462.11.86M
31 Jul 25465.3470.6455.5456.91.48M

COMPANY PROFILE

Name:
About:We are in the business of discovering, developing and commercializing small  molecule drugs for the treatment of serious diseases. Telaprevir, our lead drug  candidate, is an oral hepatitis C protease inhibitor and one of the most  advanced of a new class of antiviral treatments in clinical development that  target hepatitis C virus, or HCV, infection, a life-threatening disease. We  expect to begin a Phase 3 clinical trial of telaprevir in March 2008 to evaluate  24-week telaprevir-based treatment regimens in treatment-na?ve patients with  genotype 1 HCV.  We have built a drug discovery capability that integrates biology,  pharmacology, biophysics, chemistry, automation and information technologies in  a coordinated manner, with the goal of more efficiently identifying promising  drug candidates to address significant unmet medical needs.  ...
Sector:Consumer Durables
Industry:Major Pharmaceuticals
CUSIP:92532F100
CIK:0875320

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:24.41
PEG Ratio:1.22
EPS Ratio:-3.81
PtB:7.14
PtS:17.01
EBITDA:408.78M
Shares:256.8M
Market Cap:101.671B
52wk range:362.50 - 519.88

TECHNICALS

MA5:380.06
MA20:436.06
MA50:447.10
MA200:459.73
STO9:18.23
RSI14:31.28
WPR14:-72.21
MTM14:-73.73
ROC14:-0.16
Week High:396.72
Week Low:362.50
Month High:480.00
Month Low:362.50